메뉴 건너뛰기




Volumn 2014, Issue , 2014, Pages

Ophthalmic drug dosage forms: Characterisation and research methods

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AGENTS ACTING ON THE EYE; ARTIFICIAL TEAR; CARBOMER; CIPROFLOXACIN; COLLAGEN; CYCLODEXTRIN; CYCLOSPORIN A; DENDRIMER; DEXAMETHASONE; DIFLUPREDNATE; EYE DROPS; EYE OINTMENT; FLURBIPROFEN; FLURBIPROFEN AXETIL; GENTAMICIN; HYDROXYPROPYLMETHYLCELLULOSE; LIPOSOME; MUCIN; NIOSOME; PHENYLEPHRINE; PILOCARPINE; POLOXAMER; POLYACRYLIC ACID; POLYMACON; POLYMER; PRODRUG; SULFAFURAZOLE; TIMOLOL; TIMOLOL MALEATE; DRUG DOSAGE FORM;

EID: 84897548988     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/861904     Document Type: Review
Times cited : (212)

References (86)
  • 1
    • 84862728671 scopus 로고    scopus 로고
    • Ocular drug delivery system: A reference to natural polymers
    • Pahuja P., Arora S., Pawar P., Ocular drug delivery system: a reference to natural polymers. Expert Opinion on Drug Delivery 2012 9 7 837 861
    • (2012) Expert Opinion on Drug Delivery , vol.9 , Issue.7 , pp. 837-861
    • Pahuja, P.1    Arora, S.2    Pawar, P.3
  • 3
    • 63949084823 scopus 로고    scopus 로고
    • Recent perspectives in ocular drug delivery
    • 2-s2.0-63949084823 10.1007/s11095-008-9694-0
    • Gaudana R., Jwala J., Boddu S. H. S., Mitra A. K., Recent perspectives in ocular drug delivery. Pharmaceutical Research 2009 26 5 1197 1216 2-s2.0-63949084823 10.1007/s11095-008-9694-0
    • (2009) Pharmaceutical Research , vol.26 , Issue.5 , pp. 1197-1216
    • Gaudana, R.1    Jwala, J.2    Boddu, S.H.S.3    Mitra, A.K.4
  • 6
    • 0642309134 scopus 로고    scopus 로고
    • Stability testing of new drug substances and products Q1A (R2)
    • International Conference on Harmonization
    • International Conference on Harmonization, Stability testing of new drug substances and products Q1A (R2). Federal Register 2003 68 225 65717 65718
    • (2003) Federal Register , vol.68 , Issue.225 , pp. 65717-65718
  • 7
    • 84897495399 scopus 로고    scopus 로고
    • Warsaw, Poland The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
    • Polish Pharmacopoeia 2008 8, part 1 Warsaw, Poland The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
    • (2008) Polish Pharmacopoeia , vol.81
  • 11
    • 23944453408 scopus 로고    scopus 로고
    • Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate
    • DOI 10.1016/j.ijpharm.2005.05.036, PII S0378517305003431
    • Yamaguchi M., Yasueda S.-I., Isowaki A., Yamamoto M., Kimura M., Inada K., Ohtori A., Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. International Journal of Pharmaceutics 2005 301 1-2 121 128 2-s2.0-23944453408 10.1016/j.ijpharm.2005.05. 036 (Pubitemid 41206597)
    • (2005) International Journal of Pharmaceutics , vol.301 , Issue.1-2 , pp. 121-128
    • Yamaguchi, M.1    Yasueda, S.-I.2    Isowaki, A.3    Yamamoto, M.4    Kimura, M.5    Inada, K.6    Ohtori, A.7
  • 12
    • 47949125220 scopus 로고    scopus 로고
    • Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels
    • 2-s2.0-47949125220 10.1016/j.ijpharm.2008.05.028
    • Kapoor Y., Chauhan A., Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. International Journal of Pharmaceutics 2008 361 1-2 222 229 2-s2.0-47949125220 10.1016/j.ijpharm.2008.05. 028
    • (2008) International Journal of Pharmaceutics , vol.361 , Issue.1-2 , pp. 222-229
    • Kapoor, Y.1    Chauhan, A.2
  • 13
    • 79957513828 scopus 로고    scopus 로고
    • Novel NSAIDs ophthalmic formulation: Flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect
    • 2-s2.0-79957513828 10.1016/j.ijpharm.2011.03.041
    • Shen J., Gan L., Zhu C., Zhang X., Dong Y., Jiang M., Zhu J., Gan Y., Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect. International Journal of Pharmaceutics 2011 412 1-2 115 122 2-s2.0-79957513828 10.1016/j.ijpharm.2011.03. 041
    • (2011) International Journal of Pharmaceutics , vol.412 , Issue.1-2 , pp. 115-122
    • Shen, J.1    Gan, L.2    Zhu, C.3    Zhang, X.4    Dong, Y.5    Jiang, M.6    Zhu, J.7    Gan, Y.8
  • 15
    • 0343026463 scopus 로고    scopus 로고
    • Prodrugs for improved ocular drug delivery
    • DOI 10.1016/0169-409X(95)00107-I
    • Järvinen T., Järvinen K., Prodrugs for improved ocular drug delivery. Advanced Drug Delivery Reviews 1996 19 2 203 224 (Pubitemid 26191621)
    • (1996) Advanced Drug Delivery Reviews , vol.19 , Issue.2 , pp. 203-224
    • Jarvinen, T.1    Jarvinen, K.2
  • 16
    • 0036117863 scopus 로고    scopus 로고
    • Cyclodextrins in eye drop formulations: Enhanced topical delivery of corticosteroids to the eye
    • DOI 10.1034/j.1600-0420.2002.800205.x
    • Loftsson T., Stefánsson E., Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmologica Scandinavica 2002 80 2 144 150 2-s2.0-0036117863 10.1034/j.1600-0420.2002.800205.x (Pubitemid 34406845)
    • (2002) Acta Ophthalmologica Scandinavica , vol.80 , Issue.2 , pp. 144-150
    • Loftsson, T.1    Stefansson, E.2
  • 17
    • 84870225751 scopus 로고    scopus 로고
    • Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses
    • Jung H. J., Abou-Jaoude M., Carbia B. E., Plummer C., Chauhan A., Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses. Journal of Controlled Release 2013 165 1 82 89
    • (2013) Journal of Controlled Release , vol.165 , Issue.1 , pp. 82-89
    • Jung, H.J.1    Abou-Jaoude, M.2    Carbia, B.E.3    Plummer, C.4    Chauhan, A.5
  • 18
    • 58149350295 scopus 로고    scopus 로고
    • Uptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materials
    • 2-s2.0-58149350295
    • Hui A., Boone A., Jones L., Uptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materials. Eye & Contact Lens 2008 34 5 266 271 2-s2.0-58149350295
    • (2008) Eye & Contact Lens , vol.34 , Issue.5 , pp. 266-271
    • Hui, A.1    Boone, A.2    Jones, L.3
  • 19
    • 70349138441 scopus 로고    scopus 로고
    • Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses
    • 2-s2.0-70349138441 10.1097/ICL.0b013e3181b26c49
    • Boone A., Hui A., Jones L., Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye and Contact Lens 2009 35 5 260 267 2-s2.0-70349138441 10.1097/ICL.0b013e3181b26c49
    • (2009) Eye and Contact Lens , vol.35 , Issue.5 , pp. 260-267
    • Boone, A.1    Hui, A.2    Jones, L.3
  • 20
    • 80052534766 scopus 로고    scopus 로고
    • Extended cyclosporine delivery by silicone-hydrogel contact lenses
    • 2-s2.0-80052534766 10.1016/j.jconrel.2011.06.028
    • Peng C.-C., Chauhan A., Extended cyclosporine delivery by silicone-hydrogel contact lenses. Journal of Controlled Release 2011 154 3 267 274 2-s2.0-80052534766 10.1016/j.jconrel.2011.06.028
    • (2011) Journal of Controlled Release , vol.154 , Issue.3 , pp. 267-274
    • Peng, C.-C.1    Chauhan, A.2
  • 21
    • 83555160860 scopus 로고    scopus 로고
    • Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: Preparation and in vitro/in vivo evaluation
    • 2-s2.0-83555160860 10.1208/s12249-011-9701-3
    • Aburahma M. H., Mahmoud A. A., Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation. AAPS PharmSciTech 2011 12 4 1335 1347 2-s2.0-83555160860 10.1208/s12249-011- 9701-3
    • (2011) AAPS PharmSciTech , vol.12 , Issue.4 , pp. 1335-1347
    • Aburahma, M.H.1    Mahmoud, A.A.2
  • 22
    • 84864699578 scopus 로고    scopus 로고
    • Comparative evaluation of polymer combination in the design of brimonidine tartrate ocular inserts
    • Goudanavar P., Ambhore N., Hiremath D., Udupi R., Comparative evaluation of polymer combination in the design of brimonidine tartrate ocular inserts. Indian Drugs 2012 49 7 30 35
    • (2012) Indian Drugs , vol.49 , Issue.7 , pp. 30-35
    • Goudanavar, P.1    Ambhore, N.2    Hiremath, D.3    Udupi, R.4
  • 23
    • 84876024556 scopus 로고    scopus 로고
    • Design, formulation and evaluation of sustained ophthalmic delivery of ciprofloxacin from ocular inserts
    • Kumar N., Sharma S., Design, formulation and evaluation of sustained ophthalmic delivery of ciprofloxacin from ocular inserts. Research Journal of Pharmacy and Technology 2013 6 3 285 286
    • (2013) Research Journal of Pharmacy and Technology , vol.6 , Issue.3 , pp. 285-286
    • Kumar, N.1    Sharma, S.2
  • 24
    • 33646484653 scopus 로고    scopus 로고
    • Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride
    • 2-s2.0-33646484653 10.1080/03639040500534101
    • Mundada A. S., Shrikhande B. K., Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Development and Industrial Pharmacy 2006 32 4 443 448 2-s2.0-33646484653 10.1080/03639040500534101
    • (2006) Drug Development and Industrial Pharmacy , vol.32 , Issue.4 , pp. 443-448
    • Mundada, A.S.1    Shrikhande, B.K.2
  • 26
    • 47349107717 scopus 로고    scopus 로고
    • Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert
    • DOI 10.1080/02713680802023104, PII 793447155
    • Mundada A. S., Shrikhande B. K., Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert. Current Eye Research 2008 33 5-6 469 475 2-s2.0-47349107717 10.1080/02713680802023104 (Pubitemid 351998850)
    • (2008) Current Eye Research , vol.33 , Issue.5-6 , pp. 469-475
    • Mundada, A.S.1    Shrikhande, B.K.2
  • 29
    • 0016467811 scopus 로고
    • Ophthalmic drug inserts
    • 2-s2.0-0016467811
    • Maichuk Y. F., Ophthalmic drug inserts. Investigative Ophthalmology 1975 14 2 87 90 2-s2.0-0016467811
    • (1975) Investigative Ophthalmology , vol.14 , Issue.2 , pp. 87-90
    • Maichuk, Y.F.1
  • 32
    • 0024384003 scopus 로고
    • Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations
    • Kelly J. A., Molyneux P. D., Smith S. A., Smith S. E., Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations. British Journal of Ophthalmology 1989 73 5 360 362 2-s2.0-0024384003 (Pubitemid 19139970)
    • (1989) British Journal of Ophthalmology , vol.73 , Issue.5 , pp. 360-362
    • Kelly, J.A.1    Molyneux, P.D.2    Smith, S.A.3    Smith, S.E.4
  • 33
    • 0028225138 scopus 로고
    • The ocular tolerability of a new ophthalmic drug delivery system (NODS)
    • DOI 10.1007/BF00919405
    • Diestelhorst M., Krieglstein G. K., The ocular tolerability of a new ophthalmic drug delivery system (NODS). International Ophthalmology 1994 18 1 1 4 2-s2.0-0028225138 10.1007/BF00919405 (Pubitemid 24223214)
    • (1994) International Ophthalmology , vol.18 , Issue.1 , pp. 1-4
    • Diestelhorst, M.1    Krieglstein, G.K.2
  • 34
    • 14844337083 scopus 로고    scopus 로고
    • Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets
    • DOI 10.1016/j.ejpb.2004.09.012
    • Weyenberg W., Vermeire A., Vandervoort J., Remon J. P., Ludwig A., Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets. European Journal of Pharmaceutics and Biopharmaceutics 2005 59 3 527 536 2-s2.0-14844337083 10.1016/j.ejpb.2004.09.012 (Pubitemid 40342527)
    • (2005) European Journal of Pharmaceutics and Biopharmaceutics , vol.59 , Issue.3 , pp. 527-536
    • Weyenberg, W.1    Vermeire, A.2    Vandervoort, J.3    Remon, J.P.4    Ludwig, A.5
  • 38
    • 77954737027 scopus 로고    scopus 로고
    • Formulation and in-vitro evaluation of ocular ciprofloxacin-containing minitablets prepared with different combinations of carbopol 974P and various cellulose derivatives
    • 2-s2.0-77954737027
    • Mortazavi S. A., Jaffariazar Z., Damercheli E., Formulation and in-vitro evaluation of ocular ciprofloxacin-containing minitablets prepared with different combinations of carbopol 974P and various cellulose derivatives. Iranian Journal of Pharmaceutical Research 2010 9 2 107 114 2-s2.0-77954737027
    • (2010) Iranian Journal of Pharmaceutical Research , vol.9 , Issue.2 , pp. 107-114
    • Mortazavi, S.A.1    Jaffariazar, Z.2    Damercheli, E.3
  • 39
    • 67349084376 scopus 로고    scopus 로고
    • Polymeric nanoparticulate system: A potential approach for ocular drug delivery
    • 2-s2.0-67349084376 10.1016/j.jconrel.2008.12.018
    • Nagarwal R. C., Kant S., Singh P. N., Maiti P., Pandit J. K., Polymeric nanoparticulate system: a potential approach for ocular drug delivery. Journal of Controlled Release 2009 136 1 2 13 2-s2.0-67349084376 10.1016/j.jconrel.2008. 12.018
    • (2009) Journal of Controlled Release , vol.136 , Issue.1 , pp. 2-13
    • Nagarwal, R.C.1    Kant, S.2    Singh, P.N.3    Maiti, P.4    Pandit, J.K.5
  • 40
    • 84870709485 scopus 로고    scopus 로고
    • Ocular drug delivery: A clue from nanotechnology
    • 10.3389/fphar.2012.00188
    • Bucolo C., Drago F., Salomone S., Ocular drug delivery: a clue from nanotechnology. Frontiers in Pharmacology 2012 3, article 188 10.3389/fphar.2012.00188
    • (2012) Frontiers in Pharmacology , vol.3188
    • Bucolo, C.1    Drago, F.2    Salomone, S.3
  • 41
    • 39149109626 scopus 로고    scopus 로고
    • Nanotechnology in ocular drug delivery
    • 2-s2.0-39149109626 10.1016/j.drudis.2007.10.021
    • Sahoo S. K., Dilnawaz F., Krishnakumar S., Nanotechnology in ocular drug delivery. Drug Discovery Today 2008 13 3-4 144 151 2-s2.0-39149109626 10.1016/j.drudis.2007.10.021
    • (2008) Drug Discovery Today , vol.13 , Issue.3-4 , pp. 144-151
    • Sahoo, S.K.1    Dilnawaz, F.2    Krishnakumar, S.3
  • 43
    • 0346787779 scopus 로고    scopus 로고
    • Vesicular systems in ocular drug delivery: An overview
    • DOI 10.1016/j.ijpharm.2003.09.016
    • Kaur I. P., Garg A., Singla A. K., Aggarwal D., Vesicular systems in ocular drug delivery: an overview. International Journal of Pharmaceutics 2004 269 1 1 14 2-s2.0-0346787779 10.1016/j.ijpharm.2003.09.016 (Pubitemid 38035207)
    • (2004) International Journal of Pharmaceutics , vol.269 , Issue.1 , pp. 1-14
    • Kaur, I.P.1    Garg, A.2    Singla, A.K.3    Aggarwal, D.4
  • 44
    • 34548312124 scopus 로고    scopus 로고
    • Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations
    • DOI 10.1016/j.ijpharm.2007.04.013, PII S0378517307003316
    • Budai L., Hajdú M., Budai M., Gróf P., Béni S., Noszál B., Klebovich I., Antal I., Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. International Journal of Pharmaceutics 2007 343 1-2 34 40 2-s2.0-34548312124 10.1016/j.ijpharm.2007.04. 013 (Pubitemid 47334864)
    • (2007) International Journal of Pharmaceutics , vol.343 , Issue.1-2 , pp. 34-40
    • Budai, L.1    Hajdu, M.2    Budai, M.3    Grof, P.4    Beni, S.5    Noszal, B.6    Klebovich, I.7    Antal, I.8
  • 47
    • 38349134916 scopus 로고    scopus 로고
    • Dendrimers as drug carriers: Applications in different routes of drug administration
    • 2-s2.0-38349134916 10.1002/jps.21079
    • Cheng Y., Xu Z., Ma M., Xu T., Dendrimers as drug carriers: applications in different routes of drug administration. Journal of Pharmaceutical Sciences 2008 97 1 123 143 2-s2.0-38349134916 10.1002/jps.21079
    • (2008) Journal of Pharmaceutical Sciences , vol.97 , Issue.1 , pp. 123-143
    • Cheng, Y.1    Xu, Z.2    Ma, M.3    Xu, T.4
  • 48
    • 11844250522 scopus 로고    scopus 로고
    • Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide
    • DOI 10.1016/j.jconrel.2004.09.015, PII S0168365904004456
    • Vandamme T. F., Brobeck L., Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. Journal of Controlled Release 2005 102 1 23 38 2-s2.0-11844250522 10.1016/j.jconrel.2004. 09.015 (Pubitemid 40093773)
    • (2005) Journal of Controlled Release , vol.102 , Issue.1 , pp. 23-38
    • Vandamme, Th.F.1    Brobeck, L.2
  • 49
    • 0035997466 scopus 로고    scopus 로고
    • Quantitative in vitro comparison of fluorescein delivery to the eye via impregnated paper strip and volumetric techniques
    • Abdul-Fattah A. M., Bhargava H. N., Korb D. R., Glonek T., Finnemore V. M., Greiner J. V., Quantitative in vitro comparison of fluorescein delivery to the eye via impregnated paper strip and volumetric techniques. Optometry and Vision Science 2002 79 7 435 438 2-s2.0-0035997466 (Pubitemid 34791358)
    • (2002) Optometry and Vision Science , vol.79 , Issue.7 , pp. 435-438
    • Abdul-Fattah, A.M.1    Bhargava, H.N.2    Korb, D.R.3    Glonek, T.4    Finnemore, V.M.5    Greiner, J.V.6
  • 50
    • 0032077329 scopus 로고    scopus 로고
    • Rose bengal dye concentration and volume delivered via dye-impregnated paper strips
    • DOI 10.1097/00006324-199805000-00023
    • Snyder C., Paugh J. R., Rose bengal dye concentration and volume delivered via dye-impregnated paper strips. Optometry and Vision Science 1998 75 5 339 341 2-s2.0-0032077329 10.1097/00006324-199805000-00023 (Pubitemid 28268553)
    • (1998) Optometry and Vision Science , vol.75 , Issue.5 , pp. 339-341
    • Snyder, C.1    Paugh, J.R.2
  • 52
    • 0031390411 scopus 로고    scopus 로고
    • The use of small volume ocular sprays to improve the bioavailability of topically applied ophthalmic drugs
    • DOI 10.1016/S0939-6411(97)00071-4, PII S0939641197000714
    • Martini L. G., Embleton J. K., Malcolmson R. J., Wilson C. G., The use of small volume ocular sprays to improve the bioavailability of topically applied ophthalmic drugs. European Journal of Pharmaceutics and Biopharmaceutics 1997 44 2 121 126 2-s2.0-0031390411 10.1016/S0939-6411(97)00071-4 (Pubitemid 28539145)
    • (1997) European Journal of Pharmaceutics and Biopharmaceutics , vol.44 , Issue.2 , pp. 121-126
    • Martini, L.G.1    Embleton, J.K.2    Malcolmson, R.J.3    Wilson, C.G.4
  • 53
    • 31544465937 scopus 로고    scopus 로고
    • Iontophoresis: A non-invasive ocular drug delivery
    • DOI 10.1016/j.jconrel.2005.09.049, PII S0168365905005286
    • Eljarrat-Binstock E., Domb A. J., Iontophoresis: a non-invasive ocular drug delivery. Journal of Controlled Release 2006 110 3 479 489 2-s2.0-31544465937 10.1016/j.jconrel.2005.09.049 (Pubitemid 43163439)
    • (2006) Journal of Controlled Release , vol.110 , Issue.3 , pp. 479-489
    • Eljarrat-Binstock, E.1    Domb, A.J.2
  • 55
    • 84865999782 scopus 로고    scopus 로고
    • Formulation and evaluation of ophthalmic delivery of fluconazole from ion activated in situ gelling system
    • Nagargoje S., Phatak A., Bhingare C., Chaudhari S., Formulation and evaluation of ophthalmic delivery of fluconazole from ion activated in situ gelling system. Der Pharmacia Lettre 2012 4 4 1228 1235
    • (2012) Der Pharmacia Lettre , vol.4 , Issue.4 , pp. 1228-1235
    • Nagargoje, S.1    Phatak, A.2    Bhingare, C.3    Chaudhari, S.4
  • 56
    • 84897477373 scopus 로고    scopus 로고
    • Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect
    • Prajapati P. A., Patel M. M., Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect. International Journal of Pharmaceutical and Applied Sciences 2010 1 2 70 78
    • (2010) International Journal of Pharmaceutical and Applied Sciences , vol.1 , Issue.2 , pp. 70-78
    • Prajapati, P.A.1    Patel, M.M.2
  • 57
    • 84862849131 scopus 로고    scopus 로고
    • Protein particulate detection issues in biotherapeutics development-current status
    • 2-s2.0-84860580885 10.1208/s12249-012-9793-4
    • Das T. K., Protein particulate detection issues in biotherapeutics development-current status. AAPS PharmSciTech 2012 13 2 732 746 2-s2.0-84860580885 10.1208/s12249-012-9793-4
    • (2012) AAPS PharmSciTech , vol.13 , Issue.2 , pp. 732-746
    • Das, T.K.1
  • 58
    • 0034690034 scopus 로고    scopus 로고
    • Formulation and evaluation of ophthalmic preparations of acetazolamide
    • DOI 10.1016/S0378-5173(00)00359-8, PII S0378517300003598
    • Kaur I. P., Singh M., Kanwar M., Formulation and evaluation of ophthalmic preparations of acetazolamide. International Journal of Pharmaceutics 2000 199 2 119 127 2-s2.0-0034690034 10.1016/S0378-5173(00)00359-8 (Pubitemid 30236183)
    • (2000) International Journal of Pharmaceutics , vol.199 , Issue.2 , pp. 119-127
    • Kaur, I.P.1    Singh, M.2    Kanwar, M.3
  • 59
    • 84897525328 scopus 로고    scopus 로고
    • Rockville, Md, USA United States Pharmacopeial Convention
    • U.S. Pharmacopeia 35 2012 Rockville, Md, USA United States Pharmacopeial Convention
    • (2012) U.S. Pharmacopeia 35
  • 60
    • 33846645366 scopus 로고    scopus 로고
    • 2O lamellar liquid crystal
    • DOI 10.1016/j.colsurfa.2006.08.041, PII S0927775706006613
    • 2O lamellar liquid crystal. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2007 295 1-3 130 134 2-s2.0-33846645366 10.1016/j.colsurfa.2006.08.041 (Pubitemid 46187015)
    • (2007) Colloids and Surfaces A: Physicochemical and Engineering Aspects , vol.295 , Issue.1-3 , pp. 130-134
    • Liu, T.1    Guo, R.2
  • 62
    • 31544457644 scopus 로고    scopus 로고
    • Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles
    • DOI 10.1211/jpp.58.2.0004
    • Kao H.-J., Lin H.-R., Lo Y.-L., Yu S.-P., Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. Journal of Pharmacy and Pharmacology 2006 58 2 179 186 2-s2.0-31544457644 10.1211/jpp.58.2.0004 (Pubitemid 43164273)
    • (2006) Journal of Pharmacy and Pharmacology , vol.58 , Issue.2 , pp. 179-186
    • Kao, H.-J.1    Lin, H.-R.2    Lo, Y.-L.3    Yu, S.-P.4
  • 63
    • 3543046202 scopus 로고    scopus 로고
    • Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity
    • DOI 10.1023/B:PHAM.0000026432.75781.cb
    • De Campos A. M., Diebold Y., Carvalho E. L. S., Sánchez A., Alonso M. J., Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research 2004 21 5 803 810 2-s2.0-3543046202 10.1023/B:PHAM.0000026432.75781.cb (Pubitemid 39011304)
    • (2004) Pharmaceutical Research , vol.21 , Issue.5 , pp. 803-810
    • De Campos, A.M.1    Diebold, Y.2    Carvalho, E.L.S.3    Sanchez, A.4    Alonso, M.J.5
  • 64
    • 84863956410 scopus 로고    scopus 로고
    • Development of acyclovir-loaded bovine serum albumin nanoparticles for ocular drug delivery
    • Noomwong P., Ratanasak W., Polnok A., Sarisuta N., Development of acyclovir-loaded bovine serum albumin nanoparticles for ocular drug delivery. International Journal of Drug Delivery 2011 3 4 669 675
    • (2011) International Journal of Drug Delivery , vol.3 , Issue.4 , pp. 669-675
    • Noomwong, P.1    Ratanasak, W.2    Polnok, A.3    Sarisuta, N.4
  • 67
    • 0024431088 scopus 로고
    • Some studies into the properties of indomethacin suspensions intended for ophthalmic use
    • Vulovic N., Primorac M., Stupar M., Ford J. L., Some studies into the properties of indomethacin suspensions intended for ophthalmic use. International Journal of Pharmaceutics 1989 55 2-3 123 128 2-s2.0-0024431088 (Pubitemid 19253781)
    • (1989) International Journal of Pharmaceutics , vol.55 , Issue.2-3 , pp. 123-128
    • Vulovic, N.1    Primorac, M.2    Stupar, M.3    Ford, J.L.4
  • 68
    • 0029806755 scopus 로고    scopus 로고
    • Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice
    • Francis B. A., Chang E. L., Haik B. G., Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice. Ophthalmology 1996 103 11 1884 1888 2-s2.0-0029806755 (Pubitemid 26403744)
    • (1996) Ophthalmology , vol.103 , Issue.11 , pp. 1884-1888
    • Francis, B.A.1    Chang, E.L.2    Haik, B.G.3
  • 69
    • 77953291167 scopus 로고    scopus 로고
    • Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates
    • 2-s2.0-77953291167 10.1007/s11095-010-0073-2
    • Filipe V., Hawe A., Jiskoot W., Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharmaceutical Research 2010 27 5 796 810 2-s2.0-77953291167 10.1007/s11095-010-0073-2
    • (2010) Pharmaceutical Research , vol.27 , Issue.5 , pp. 796-810
    • Filipe, V.1    Hawe, A.2    Jiskoot, W.3
  • 70
    • 79961135205 scopus 로고    scopus 로고
    • Design and evaluation of ciprofloxacin hydrochloride ocular inserts
    • 2-s2.0-79961135205
    • Attia M. A., Al-Azizi M., Hashish M. S., Design and evaluation of ciprofloxacin hydrochloride ocular inserts. International Journal of PharmTech Research 2011 3 3 1750 1763 2-s2.0-79961135205
    • (2011) International Journal of PharmTech Research , vol.3 , Issue.3 , pp. 1750-1763
    • Attia, M.A.1    Al-Azizi, M.2    Hashish, M.S.3
  • 71
    • 0034518242 scopus 로고    scopus 로고
    • Stability storage and testing of ophthalmic products for global registration
    • DOI 10.1081/DDC-100102304
    • Matthews B. R., Wall G. M., Stability storage and testing of ophthalmic products for global registration. Drug Development and Industrial Pharmacy 2000 26 12 1227 1237 2-s2.0-0034518242 10.1081/DDC-100102304 (Pubitemid 32037419)
    • (2000) Drug Development and Industrial Pharmacy , vol.26 , Issue.12 , pp. 1227-1237
    • Matthews, B.R.1    Wall, G.M.2
  • 73
    • 0023816425 scopus 로고
    • Collagen ophthalmic inserts for pilocarpine drug delivery system
    • 2-s2.0-0023816425
    • Vasantha R., Sehgal P. K., Rao K. P., Collagen ophthalmic inserts for pilocarpine drug delivery system. International Journal of Pharmaceutics 1988 47 1-3 95 102 2-s2.0-0023816425
    • (1988) International Journal of Pharmaceutics , vol.47 , Issue.1-3 , pp. 95-102
    • Vasantha, R.1    Sehgal, P.K.2    Rao, K.P.3
  • 75
    • 0031892629 scopus 로고    scopus 로고
    • In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine
    • DOI 10.1021/js970090e
    • Desai S. D., Blanchard J., In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. Journal of Pharmaceutical Sciences 1998 87 2 226 230 2-s2.0-0031892629 10.1021/js970090e (Pubitemid 28081333)
    • (1998) Journal of Pharmaceutical Sciences , vol.87 , Issue.2 , pp. 226-230
    • Desai, S.D.1    Blanchard, J.2
  • 76
    • 57049140409 scopus 로고    scopus 로고
    • Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
    • 2-s2.0-57049140409 10.1016/j.jconrel.2008.09.086
    • Danhier F., Lecouturier N., Vroman B., Jérôme C., Marchand-Brynaert J., Feron O., Préat V., Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Journal of Controlled Release 2009 133 1 11 17 2-s2.0-57049140409 10.1016/j.jconrel.2008.09.086
    • (2009) Journal of Controlled Release , vol.133 , Issue.1 , pp. 11-17
    • Danhier, F.1    Lecouturier, N.2    Vroman, B.3    Jérôme, C.4    Marchand-Brynaert, J.5    Feron, O.6    Préat, V.7
  • 77
    • 12444299613 scopus 로고    scopus 로고
    • Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability
    • DOI 10.1023/A:1023290514575
    • Giannavola C., Bucolo C., Maltese A., Paolino D., Vandelli M. A., Puglisi G., Lee V. H. L., Fresta M., Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharmaceutical Research 2003 20 4 584 590 2-s2.0-12444299613 10.1023/A:1023290514575 (Pubitemid 36438901)
    • (2003) Pharmaceutical Research , vol.20 , Issue.4 , pp. 584-590
    • Giannavola, C.1    Bucolo, C.2    Maltese, A.3    Paolino, D.4    Vandelli, M.A.5    Puglisi, G.6    Lee, V.H.L.7    Fresta, M.8
  • 78
    • 84897556628 scopus 로고    scopus 로고
    • Design and evaluation of soluble ocular drug insert for controlled release of acyclovir
    • Kaul S., Kumar G., Kothiyal P., Design and evaluation of soluble ocular drug insert for controlled release of acyclovir. International Journal of Drug Research and Technology 2012 2 5 393 398
    • (2012) International Journal of Drug Research and Technology , vol.2 , Issue.5 , pp. 393-398
    • Kaul, S.1    Kumar, G.2    Kothiyal, P.3
  • 79
    • 79955932209 scopus 로고    scopus 로고
    • Enhancement of anti-glaucoma potential by novel ocular drug delivery system
    • 2-s2.0-79955932209
    • Gupta S., Gilhotra R. M., Enhancement of anti-glaucoma potential by novel ocular drug delivery system. International Journal of Pharmacy and Pharmaceutical Sciences 2011 3 2 55 58 2-s2.0-79955932209
    • (2011) International Journal of Pharmacy and Pharmaceutical Sciences , vol.3 , Issue.2 , pp. 55-58
    • Gupta, S.1    Gilhotra, R.M.2
  • 80
    • 79954519553 scopus 로고    scopus 로고
    • Evaluation of two in situ gelling systems for ocular delivery of Moxifloxacin: In vitro and in vivo studies
    • 2-s2.0-79954519553
    • El-Laithy H. M., Nesseem D. I., Shoukry M., Evaluation of two in situ gelling systems for ocular delivery of Moxifloxacin: in vitro and in vivo studies. Journal of Chemical and Pharmaceutical Research 2011 3 2 66 79 2-s2.0-79954519553
    • (2011) Journal of Chemical and Pharmaceutical Research , vol.3 , Issue.2 , pp. 66-79
    • El-Laithy, H.M.1    Nesseem, D.I.2    Shoukry, M.3
  • 82
    • 44849130751 scopus 로고    scopus 로고
    • Controlled ocular delivery of acyclovir through rate controlling ocular insert of eudragit: A technical note
    • 2-s2.0-44849130751 10.1208/s12249-008-9032-1
    • Khan S., Ali A., Singhavi D., Yeole P., Controlled ocular delivery of acyclovir through rate controlling ocular insert of eudragit: a technical note. AAPS PharmSciTech 2008 9 1 169 173 2-s2.0-44849130751 10.1208/s12249-008-9032-1
    • (2008) AAPS PharmSciTech , vol.9 , Issue.1 , pp. 169-173
    • Khan, S.1    Ali, A.2    Singhavi, D.3    Yeole, P.4
  • 83
    • 3543014387 scopus 로고    scopus 로고
    • Preparation and evaluation of ocular inserts containing norfloxacin
    • Rao V., Shyale S., Preparation and evaluation of ocular inserts containing norfloxacin. Turkish Journal of Medical Sciences 2004 34 4 239 246 2-s2.0-3543014387 (Pubitemid 39013716)
    • (2004) Turkish Journal of Medical Sciences , vol.34 , Issue.4 , pp. 239-246
    • Rao, V.1    Shyale, S.2
  • 84
    • 35848948383 scopus 로고    scopus 로고
    • In vitro and in vivo evaluation of ocular inserts of ofloxacin
    • Tanwar Y. S., Patel D., Sisodia S. S., In vitro and in vivo evaluation of ocular inserts of ofloxacin. Daru 2007 15 3 139 145 2-s2.0-35848948383 (Pubitemid 350058640)
    • (2007) Daru , vol.15 , Issue.3 , pp. 139-145
    • Tanwar, Y.S.1    Patel, D.2    Sisodia, S.S.3
  • 86
    • 0035348060 scopus 로고    scopus 로고
    • The Draize eye test
    • 2-s2.0-0035348060
    • Wilhelmus K. R., The Draize eye test. Survey of Ophthalmology 2001 45 6 493 515 2-s2.0-0035348060
    • (2001) Survey of Ophthalmology , vol.45 , Issue.6 , pp. 493-515
    • Wilhelmus, K.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.